University of Hertfordshire

Professor Diana Gorog

Professor

Publications

  1. 2019
  2. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

    Hausenloy, D., Kharbanda, R., Møller, U. K., Ramlall, M., Aarøe, J., Butler, R., Bulluck, H., Clayton, T., Dana, A., Dodd, M., Engstrom, T., Evans, R., Lassen, J. F., Christensen, E., Garcia-Ruiz, J. M., Gorog, D., Hjort, J., Houghton, R., Ibanez, B., Knight, R. & 22 othersLippert, F. K., Lønborg, J., Maeng, M., Milasinovic, D., More, R., Nicholas, J. M., Jensen, L. O., Perkins, A., Radovanovic, N., Rakhit, R., Ravkilde, J., Ryding, A. D., Schmidt, M. R., Riddervold, I. S., Sørensen, H. T., Stankovic, G., Varma, M., Webb, I., Terkelsen, C. J., Greenwood, J., Yellon, D. & Bøtker†, H. E., 6 Sep 2019, In : The Lancet.

    Research output: Contribution to journalArticle

  3. Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy—Current Evidence and Practice

    Geisler, T., Jorbenadze, R., Popov, A-F., Mueller, K. L., Rath, D., Droppa, M., Schreieck, J., Seizer, P., Storey, R. F., Kristensen, S. D., Rubboli, A., Gorog, D., Aradi, D., Sibbing, D., Huber, K., Gawaz, M. & Berg, J. T., 17 Aug 2019, In : Thrombosis and haemostasis.

    Research output: Contribution to journalArticle

  4. MINOCA presenting with STEMI – incidence, aetiology and outcome in a contemporaneous cohort

    Gue, Y. X., Corballis, N., Ryding, A., Kaski, J. C. & Gorog, D., 20 Jul 2019, In : Journal of Thrombosis and Thrombolysis.

    Research output: Contribution to journalArticle

  5. Impaired spontaneous (endogenous) fibrinolytic status: Are we ready for a new cardiovascular risk factor?

    Gorog, D. & Lip, G. Y. H., 18 Jul 2019, (Accepted/In press) In : Journal of the American College of Cardiology.

    Research output: Contribution to journalArticle

  6. Impact of lipoprotein apheresis on thrombotic parameters in patients with refractory angina and raised lipoprotein(a): Findings from a randomized controlled cross-over trial

    Khan, T. Z., Gorog, D. A., Arachchillage, D. J., Ahnström, J., Rhodes, S., Donovan, J., Banya, W., Pottle, A., Barbir, M. & Pennell, D. J., 2 Jul 2019, In : Journal of Clinical Lipidology.

    Research output: Contribution to journalArticle

  7. Apixaban Enhances Endogenous Fibrinolysis in Patients with Atrial Fibrillation

    Spinthakis, N., Gue, Y. X., Farag, M., Srinivasan, M., Wellsted, D., Lip, G. Y. H., Arachchillage, D. RJ. & Gorog, D., 25 Jun 2019, In : EP Europace.

    Research output: Contribution to journalArticle

  8. A case of repetitivemyocardial infarction with unobstructed coronaries due to Churg-Strauss syndrome

    Gue, Y. X., Prasad, S., Isenberg, D. & Gorog, D. A., 1 Jun 2019, In : European Heart Journal - Case Reports. 3, 2, 5 p., ytz041.

    Research output: Contribution to journalArticle

  9. Relationship of platelet reactivity and inflammatory markers to recurrent adverse events in patients with ST-elevation myocardial infarction

    Adatia, K., Farag, M., Gue, Y. X., Srinivasan, M. & Gorog, D., 1 May 2019, In : Thrombosis and haemostasis.

    Research output: Contribution to journalArticle

  10. Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture

    Spinthakis, N., Gue, Y., Farag, M., Ren, G., Srinivasan, M., Baydoun, A. & Gorog, D. A., 1 Apr 2019, In : Journal of Thrombosis and Thrombolysis. 47, 3, p. 392-395 4 p.

    Research output: Contribution to journalArticle

  11. Effect of P2Y(12) inhibitors on thrombus stability and endogenous fibrinolysis

    Gorog, D., Spinthakis, N., Farag, M., Gue, Y. X., Srinivasan, M. & Wellsted, D., 1 Jan 2019, In : Thrombosis Research. 173, p. 102-108 7 p.

    Research output: Contribution to journalArticle

  12. 2018
  13. METoclopramide Administration as a Strategy to Overcome MORPHine-ticagrelOr Interaction in PatientS with Unstable Angina PectorIS-The METAMORPHOSIS Trial

    Sikora, J., Barańska, M., Buszko, K., Skibińska, N., Stroka, W., Pstrągowski, K., Siller-Matula, J. M., Bernd, J., Gorog, D., Navarese, E. P., Marszałł, M. P. & Kubica, J., 19 Nov 2018, In : Thrombosis and haemostasis. 118, 12, p. 2126-2133 7 p.

    Research output: Contribution to journalArticle

  14. Assessment of adherence to medication in patients after myocardial infarction treated with percutaneous coronary intervention. Is there a place for newself-reported questionnaires?

    Kubica, A., Kosobucka, A., Fabiszak, T., Gorog, D. & Siller-Matula, J. M., 13 Sep 2018, In : Current Medical Research and Opinion. 35, 2, p. 341-349

    Research output: Contribution to journalArticle

  15. Metabolism of ticagrelor in patients with acute coronary syndromes.

    Adamski, P., Buszko, K., Sikora, J., Niezgoda, P., Barańska, M., Ostrowska, M., Paciorek, P., Navarese, E. P., Gorog, D. & Kubica, J., 6 Sep 2018, In : Scientific Reports. 8, p. 1-8 8 p., 11746.

    Research output: Contribution to journalArticle

  16. Lowering the risk of stroke prevention: Managing bleeding complications

    Gorog, D., 3 Jul 2018, In : International Journal of Cardiology. 274, p. 351-352

    Research output: Contribution to journalEditorial

  17. Morphine Analgesia Pre-PPCI Is Associated with Prothrombotic State, Reduced Spontaneous Reperfusion and Greater Infarct Size

    Farag, M., Spinthakis, N., Srinivasan, M., Sullivan, K., Wellsted, D. & Gorog, D. A., 1 Mar 2018, In : Thrombosis and haemostasis. 118, 3, p. 601-612 12 p.

    Research output: Contribution to journalArticle

  18. More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions.

    Spinthakis, N., Farag, M., Rocca, B. & Gorog, D., 6 Feb 2018, In : Journal of the American Heart Association. 7, 3, p. 1-10 10 p.

    Research output: Contribution to journalArticle

  19. Should STEMI Patients Receive Opiate Analgesia? The Morphine Paradox

    Farag, M., Spinthakis, N., Srinivasan, M. & Gorog, D. A., 17 Jan 2018, In : Current vascular pharmacology. 16, 5, p. 477-483 7 p.

    Research output: Contribution to journalReview article

  20. Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice.

    Vimalesvaran, K., Dockrill, S. J. & Gorog, D., 8 Jan 2018, In : Vascular Health and Risk Management. 14, p. 13-21 8 p.

    Research output: Contribution to journalArticle

  21. Controversies in the cath lab: Navigating contemporary conundrums before, during and after intervention

    Gorog, D. & Geisler, T., 2018, In : Current vascular pharmacology. 16, 5, p. 416-417 2 p.

    Research output: Contribution to journalEditorial

  22. Is there a role for oral triple therapy in patients with acute coronary syndromes without atrial fibrillation?

    Spinthakis, N., Farag, M., Akhtar, Z. & Gorog, D. A., 2018, In : Current vascular pharmacology. 16, 5, p. 427-436 10 p.

    Research output: Contribution to journalReview article

  23. 2017
  24. Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting: A meta-analysis of patients with left main coronary artery disease

    Spinthakis, N., Farag, M., Gorog, D. A., Prasad, A., Mahmood, H., Gue, Y., Wellsted, D., Nabhan, A. & Srinivasan, M., 15 Dec 2017, In : International Journal of Cardiology. 249, p. 101-106 6 p.

    Research output: Contribution to journalArticle

  25. Catheter ablation for AF improves global thrombotic profile and enhances fibrinolysis

    Niespialowska-Steuden, M., Markides, V., Farag, M., Jones, D., Hussain, W., Wong, T. & Gorog, D. A., Nov 2017, In : Journal of Thrombosis and Thrombolysis. 44, 4, p. 413-426 14 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 Next